Rega marang bathi mangsa ngarep: Relmada Corp (RLMD)
Relmada Therapeutics (RLMD) relies on the validation of resmelmetan and a potential alliance with industry behemoths. The absence of sales makes the growth of testing costs linear. The company's forward P/E ratio visualizes these processes, where the value of 0.00 characterizes this level of revenue valuation. Meanwhile, the business is implementing energy-efficient technologies to minimize the environmental footprint of its laboratories.
Relmada Corp (RLMD) - rincian metrik lan laporan keuangan
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- data ekuitas miturut neraca:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Relmada Therapeutics|RLMD - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Relmada Therapeutics|RLMD - Gunggung utang perusahaan|Utang marang nilai buku Relmada Therapeutics Inc|RLMD - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Relmada Therapeutics|Rasio cepet relmada.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
RLMD - Bathi pungkasan|Proyeksi bathi mangsa ngarep Relmada Therapeutics|RLMD - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Relmada|RLMD - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Relmada Therapeutics Inc|RLMD - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Relmada Therapeutics|RLMD - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan relmada.com|RLMD - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Relmada Therapeutics
Analisis komprehensif perusahaan:Relmada Therapeutics, Inc. RLMD
Relmada Therapeutics (RLMD) possesses a critical dependency on the success of a single antidepressant, rendering its market capitalization extremely sensitive to clinical trial results. By analyzing the company's forward P/E chart, an investor assesses the ratio of current share price to projected earnings, determining whether market expectations justify the risks of a single-product model and identifying the boundary between the asset's overvaluation and undervaluation.
Pesaing langsung
Pangali Forward P/E BIIB|NBIX - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Regencell RGC|Axsome Corp - Rega marang bathi mangsa ngarep|ACAD - Rega marang bathi mangsa ngarep|xenon-pharma.com (XENE) - Prakiraan rega marang bathi|VKTX: Pangali Forward P/E|Supernus Pharmaceuticals, Inc. (SUPN) - Pangali Forward P/E|CPRX (Catalyst Pharmaceuticals Inc) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep DNLI (Denali Corp)|Pangali Forward P/E HRMY|Pangali Forward P/E biohavenpharma.com (BHVN)|Amylyx Pharmaceuticals, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TRVI|PRAX: Prakiraan rega marang bathi|Anavex Life Sciences Corp - Rasio kapitalisasi marang bathi mangsa ngarep|CBLL: Pangali Forward P/E|Prothena - Pangali mangsa ngarep rega marang bathi|ALEC (Alector Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Annexon Biosciences ANNX|Rega marang bathi mangsa ngarep Omeros Corporation (OMER)|NGNE (Neurogene Therapeutics) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ACIU (AC Immune)|Pangali Forward P/E voyagertherapeutics.com VYGR|NMRA - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake SCLX|TVGN: Pangali Forward P/E|Rasio prakiraan rega marang bathi Alpha Cognition Inc. (ACOG)|Prakiraan rega marang bathi CGTX|Pangali Forward P/E inhibikase.com|Prakiraan rega marang bathi SAVA (Cassava Sciences)|Rasio kapitalisasi marang bathi mangsa ngarep ASRT|Pangali Forward P/E COYA (Coya Therapeutics)|Kapitalisasi marang proyeksi bathi VistaGen Therapeutics, Inc. (VTGN)|Ovid Rx - Pangali Forward P/E|acumenpharm.com (ABOS) - Prakiraan rega marang bathi|CervoMed (CRVO) - Rega marang bathi mangsa ngarep|ATHE - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Clene Inc|PEPG: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Jupiter Neurosciences Inc (JUNS)|Rega marang bathi mangsa ngarep ANVS (annovisbio.com)|Rega marang bathi mangsa ngarep Grace Therapeutics GRCE|AIFF - Prakiraan rega marang bathi|ANEW Medical, Inc. - Pangali Forward P/E|NRSN (NeuroSense Therapeutics) - Rasio rega marang bathi mangsa ngarep|Reviva Pharmaceuticals (RVPH) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep MTVA|NRXS (NeurAxis) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Helius Medical Technologies Inc. HSDT|Prakiraan rega marang bathi PASG (Passage Bio, Inc.)|Pangali Forward P/E bionomics.com.au (NEUP)|Rega marang bathi mangsa ngarep Minerva Neurosciences NERV|Pangali mangsa ngarep rega marang bathi ATHA|ADXN - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Alzamend Neuro, Inc.|cyclerion.com (CYCN) - Rega marang bathi mangsa ngarep|Protagenic Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|KTTA (Pasithea Therapeutics Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Cortigent Medical CRGT|Rega marang bathi mangsa ngarep Avenue Therapeutics, Inc. (ATXI)|Rega marang bathi mangsa ngarep BCLI (Brainstorm Cell Therapeutics Inc.)|Rega marang bathi mangsa ngarep Cara Therapeutics, Inc CARA|CHRO - Prakiraan rega marang bathi|Eliem - Pangali Forward P/E|ITCI - Pangali Forward P/E|LBPH: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep MRNS|NKGN (NKGen) - Pangali Forward P/E|Pangali Forward P/E NeuroBo Pharma|Prakiraan rega marang bathi SAGE (Sage Therapeutics, Inc.)|SNPX (synaptogen.com) - Pangali mangsa ngarep rega marang bathi|Trevena - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep VIGL (Vigil Neuroscience Inc.)|Anew Medical - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi CERE (Cerevel Corp)
